Cargando…
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
Despite advances in the pharmacologic and interventional treatment of coronary artery disease, atherosclerosis remains the leading cause of death worldwide. Atherosclerosis is a chronic inflammatory disease, and elevated expression of CCL19 and CCL21 has been observed in ruptured lesions of coronary...
Autores principales: | Akhavanpoor, Mohammadreza, Gleissner, Christian A, Gorbatsch, Stephanie, Doesch, Andreas O, Akhavanpoor, Hamidreza, Wangler, Susanne, Jahn, Frederik, Lasitschka, Felix, Katus, Hugo A, Erbel, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251537/ https://www.ncbi.nlm.nih.gov/pubmed/25473269 http://dx.doi.org/10.2147/DDDT.S72394 |
Ejemplares similares
-
Adventitial inflammation and its interaction with intimal atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014) -
Inhibition of B7-1 (CD80) by RhuDex(®) reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
por: Doesch, Andreas O, et al.
Publicado: (2014) -
Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
por: Linden, Fabian, et al.
Publicado: (2014) -
CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology
por: Erbel, Christian, et al.
Publicado: (2015) -
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
por: Helmschrott, Matthias, et al.
Publicado: (2014)